SLC19A3 - solute carrier family 19 member 3 Gene
Also Known as BBGD; THMD2; THTR2; hTHTR2; thTr-2
Species: Homo sapiens
About SLC19A3
This gene has 15 transcripts (splice variants), 265 orthologues, 2 paralogues and is associated with 6 phenotypes. Biased expression in fat (RPKM 29.6), placenta (RPKM 8.5) and 5 other tissues.
Summary
This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010]
SLC19A3 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| NM_001371411.1 | NP_001358340.1 | thiamine transporter 2 isoform 1 |
| NM_001371412.1 | NP_001358341.1 | thiamine transporter 2 isoform 1 |
| NM_001371413.1 | NP_001358342.1 | thiamine transporter 2 isoform 2 |
| NM_001371414.1 | NP_001358343.1 | thiamine transporter 2 isoform 2 |
| NM_025243.4 | NP_079519.1 | thiamine transporter 2 isoform 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
32296183 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in pyridoxine transport |
IDA
IDA: Inferred from direct assay
|
33008889 | GOA |
| involved in pyridoxine transport |
IMP
IMP: Inferred from mutant phenotype
|
35724964 | GOA |
| involved in thiamine transport |
IDA
IDA: Inferred from direct assay
|
11731220 | GOA |
| involved in thiamine transport |
IMP
IMP: Inferred from mutant phenotype
|
35724964 | GOA |
SLC19A3 Protein Structure
Folate_carrier: Reduced folate carrier (11 - 441)
- 0
- 100
- 200
- 300
- 400
- 496 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
thiamine transporter 2 |
|
SLC19A3 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM242 | Homo sapiens | Q9NWH2 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM242 | Homo sapiens | Q9NWH2 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM242 | Homo sapiens | Q9NWH2 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | GET1 | Homo sapiens | O00258 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | GET1 | Homo sapiens | O00258 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM14A | Homo sapiens | Q9Y6G1 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM14B | Homo sapiens | Q9NUH8 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM14B | Homo sapiens | Q9NUH8 | 32296183 | |
|
Intra
|
SLC19A3 | Q9BZV2 | TMEM14B | Homo sapiens | Q9NUH8 | 32296183 |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Thiamine Metabolism Dysfunction Syndrome 2 |
|
|
| Biotin-Thiamine-Responsive Basal Ganglia Disease |
|
|
| Infantile Spasms-Psychomotor Retardation-Progressive Brain Atrophy-Basal Ganglia Disease Syndrome |
|
|
| Leigh Syndrome With Leukodystrophy |
|
|
| Basal Ganglia Disease |
|
|
| Thiamine Deficiency Disease |
|
|
| Dry Beriberi |
|
|
| Wet Beriberi |
|
|
| Encephalopathy |
|
|
| Dystonia |
|
|
| Thiamine-Responsive Megaloblastic Anemia Syndrome |
|
|
| Beriberi |
|
|
| Wernicke-Korsakoff Syndrome |
|
|
| Wernicke Encephalopathy |
|
|
| Pyruvate Dehydrogenase E1-Alpha Deficiency |
|
|
| Mitochondrial Complex I Deficiency, Nuclear Type 16 |
|
|
| Kearns-Sayre Syndrome |
|
|
| Molybdenum Cofactor Deficiency, Complementation Group B |
|
|
| Biotin Deficiency |
|
|
| Mitochondrial Dna Depletion Syndrome 5 |
|
|
| Ehrlich Tumor Carcinoma |
|
|
| Biotinidase Deficiency |
|
|
| Megaloblastic Anemia |
|
|
| Ocular Motility Disease |
|
|
| Brown-Vialetto-Van Laere Syndrome |
|
|
| Chorea Gravidarum |
|
|
| Multiple Carboxylase Deficiency |
|
|
| Mitochondrial Complex I Deficiency, Nuclear Type 20 |
|
|
| Glutaric Acidemia I |
|
|
| Leigh Syndrome |
|
|
| Mitochondrial Complex I Deficiency, Nuclear Type 1 |
|
|
| Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | SLC19A3 | VGNC | VGNC:99403 |
| Mus musculus | SLC19A3 | MGD | MGI:1931307 |
| Bos taurus | SLC19A3 | VGNC | VGNC:56147 |
| Felis catus | SLC19A3 | VGNC | VGNC:82542 |
| Rattus norvegicus | SLC19A3 | RGD | RGD:1311413 |
| Others | SLC19A3 | NCBI |